The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
CalciMedica
CALC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.94
0.06
1.55%
At Close: -
$4.86
0.92
23.35%
After Hours: Jul 17, 9:25 AM EDT
15 minutes delayed
Get Report
Comment
CalciMedica (CALC) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for CalciMedica (NASDAQ:CALC) Stock
CalciMedica Stock (NASDAQ: CALC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, July 10, 2024
Oppenheimer Maintains Outperform on CalciMedi...
Benzinga Newsdesk
Tuesday, July 09, 2024
HC Wainwright & Co. Reiterates Buy on CalciMe...
Benzinga Newsdesk
CalciMedica Begins Phase 2 Trial of Auxora fo...
Benzinga Newsdesk
Monday, July 01, 2024
CalciMedica Joins Russell Microcap Index
Benzinga Newsdesk
Thursday, June 27, 2024
CalciMedica shares are trading lower. The sto...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on CalciMe...
Benzinga Newsdesk
CalciMedica shares are trading higher after t...
Benzinga Newsdesk
CalciMedica Announces Topline Data From Phase...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on CalciMe...
Benzinga Newsdesk
Monday, May 13, 2024
CalciMedica Q1 2024 GAAP EPS $0.01 Beats $(0....
Benzinga Newsdesk
Wednesday, April 24, 2024
CalciMedica Announces Last Patient Enrolled I...
Benzinga Newsdesk
Wednesday, April 03, 2024
CalciMedica And 2 Other Penny Stocks Insiders Are Buying
Avi Kapoor
Monday, April 01, 2024
Oppenheimer Maintains Outperform on CalciMedi...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on CalciMe...
Benzinga Newsdesk
Thursday, March 28, 2024
CalciMedica Q4 EPS $(0.23)
Benzinga Newsdesk
CalciMedica FY23 EPS $(7.66) Vs $(111.16) YoY
Benzinga Newsdesk
Wednesday, March 13, 2024
HC Wainwright & Co. Reiterates Buy on CalciMe...
Benzinga Newsdesk
CalciMedica Presents Data From Preclinical St...
Benzinga Newsdesk
Thursday, February 29, 2024
Reported Earlier, CalciMedica To Present Data...
Benzinga Newsdesk
Friday, February 16, 2024
JonesTrading Initiates Coverage On CalciMedic...
Benzinga Newsdesk
Tuesday, February 13, 2024
HC Wainwright & Co. Reiterates Buy on CalciMe...
Benzinga Newsdesk
Friday, February 02, 2024
Top 4 Health Care Stocks That May Crash This Quarter
Avi Kapoor
Monday, January 29, 2024
5 Value Stocks To Watch In The Healthcare Sector
Benzinga Insights
HC Wainwright & Co. Initiates Coverage On Cal...
Benzinga Newsdesk
Monday, January 22, 2024
CalciMedica Announces Private Placement Of Up...
Benzinga Newsdesk
Monday, December 11, 2023
Calcimedica's Collaborator, St. Jude Children...
Benzinga Newsdesk
Monday, November 13, 2023
Oppenheimer Reiterates Outperform on CalciMed...
Benzinga Newsdesk
Wednesday, November 08, 2023
CalciMedica Insider Trades Send a Signal
Benzinga Insights
Tuesday, November 07, 2023
Gannett And 3 Other Stocks Under $4 Insiders Are Buying
Lisa Levin
Monday, October 09, 2023
5 Value Stocks In The Healthcare Sector
Benzinga Insights
Monday, October 02, 2023
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
Monday, September 25, 2023
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Thursday, August 10, 2023
CalciMedica Q2 EPS $(1.11) Down From $(0.38) ...
Benzinga Newsdesk
Wednesday, August 09, 2023
CalciMedica Announces First Patient Enrolled ...
Benzinga Newsdesk
Friday, July 07, 2023
EF Hutton Reiterates Buy on CalciMedica, Main...
Benzinga Newsdesk
Friday, June 30, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Thursday, June 29, 2023
Director at CalciMedica Acquires Company Stock Options Worth 20,000 Shares
Benzinga Insights
CalciMedica Board Member Awarded $89K Worth of Stock Options
Benzinga Insights
Tuesday, June 27, 2023
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Tuesday, June 20, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023
Benzinga Insights
EF Hutton Initiates Coverage On CalciMedica w...
Benzinga Newsdesk
Monday, June 19, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, June 16, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, June 15, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Friday, May 19, 2023
Houston American Energy And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
Lisa Levin
Tuesday, May 16, 2023
Oppenheimer Reiterates Outperform on CalciMed...
Benzinga Newsdesk
Thursday, May 11, 2023
CalciMedica Chief Executive Officer Awarded $275K Worth of Stock Options
Benzinga Insights
Chief Scientific Officer at CalciMedica Acquires Company Stock Options Worth 68,988 Shares
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
